Next Article in Journal
Artificial Base-Directed In Vivo Formulation of Aptamer–Drug Conjugates with Albumin for Long Circulation and Targeted Delivery
Previous Article in Journal
Pyruvate Kinase M2 Promotes Hair Regeneration by Connecting Metabolic and Wnt/β-Catenin Signaling
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Andreadis et al. The Advent of a New Era in Digital Healthcare: A Role for 3D Printing Technologies in Drug Manufacturing? Pharmaceutics 2022, 14, 609

Laboratory of Pharmaceutical Technology, Department of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
*
Author to whom correspondence should be addressed.
Pharmaceutics 2022, 14(12), 2782; https://doi.org/10.3390/pharmaceutics14122782
Submission received: 13 October 2022 / Accepted: 26 October 2022 / Published: 13 December 2022

1. Figure Legend

In the original publication [1], there was a mistake in the legend for Figure 1. The legend did not include the reproduction permission from the author. The correct legend appears below.
“Figure 1. The need for personalization of pharmaceutical products and changes in product volume and variety due to product customization according to the needs of individual patients. This figure has been reproduced with permission from © 2021 Rydvikha Govender [6]”.

2. Error in Figure

In the original publication, there was a mistake in Figure 1 as published. We have used the modified form of the Figure contained in a review instead of the original Figure from the creator’s PhD thesis. The corrected Figure 1, representing an unmodified version of the original figure, appears below.
Pharmaceutics 14 02782 i001

3. Reference

A change was made in Ref. [6] mentioned in our Figure 1, in order to provide the reference for “Rydvikha Govender, Ph.D. Thesis “Integrated Product and Process Design for Mass Customization: A Road Towards Patient Access to Individualized Pharmaceutical Therapy”, February 2021, instead of Ref. from Raijada et al. The corrected reference [6] appears below:
6.
Govender, R. Integrated Product and Process Design for Mass Customization: A Road Towards Patient Access to Individualized Pharmaceutical Therapy. Ph.D. Thesis, Chalmers University of Technology, Gothenburg, Sweden, 2021.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Andreadis, I.I.; Gioumouxouzis, C.I.; Eleftheriadis, G.K.; Fatouros, D.G. The Advent of a New Era in Digital Healthcare: A Role for 3D Printing Technologies in Drug Manufacturing? Pharmaceutics 2022, 14, 609. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Andreadis, I.I.; Gioumouxouzis, C.I.; Eleftheriadis, G.K.; Fatouros, D.G. Correction: Andreadis et al. The Advent of a New Era in Digital Healthcare: A Role for 3D Printing Technologies in Drug Manufacturing? Pharmaceutics 2022, 14, 609. Pharmaceutics 2022, 14, 2782. https://doi.org/10.3390/pharmaceutics14122782

AMA Style

Andreadis II, Gioumouxouzis CI, Eleftheriadis GK, Fatouros DG. Correction: Andreadis et al. The Advent of a New Era in Digital Healthcare: A Role for 3D Printing Technologies in Drug Manufacturing? Pharmaceutics 2022, 14, 609. Pharmaceutics. 2022; 14(12):2782. https://doi.org/10.3390/pharmaceutics14122782

Chicago/Turabian Style

Andreadis, Ioannis I., Christos I. Gioumouxouzis, Georgios K. Eleftheriadis, and Dimitrios G. Fatouros. 2022. "Correction: Andreadis et al. The Advent of a New Era in Digital Healthcare: A Role for 3D Printing Technologies in Drug Manufacturing? Pharmaceutics 2022, 14, 609" Pharmaceutics 14, no. 12: 2782. https://doi.org/10.3390/pharmaceutics14122782

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop